NEXUS GOLD CORP- A (NXS.CA) Fundamental Analysis & Valuation

TSX-V:NXS • CA65345J3038

Current stock price

0.31 CAD
-0.02 (-6.06%)
Last:

This NXS.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NXS.CA Profitability Analysis

1.1 Basic Checks

  • NXS had positive earnings in the past year.
  • In the past year NXS has reported a negative cash flow from operations.
  • NXS had negative earnings in each of the past 5 years.
  • In the past 5 years NXS always reported negative operating cash flow.
NXS.CA Yearly Net Income VS EBIT VS OCF VS FCFNXS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1M -2M -3M -4M -5M

1.2 Ratios

Industry RankSector Rank
ROA 9.41%
ROE N/A
ROIC N/A
ROA(3y)-71.2%
ROA(5y)-67.65%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NXS.CA Yearly ROA, ROE, ROICNXS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10K -20K -30K -40K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for NXS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NXS.CA Yearly Profit, Operating, Gross MarginsNXS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. NXS.CA Health Analysis

2.1 Basic Checks

  • NXS has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for NXS has been increased compared to 5 years ago.
  • The debt/assets ratio for NXS is higher compared to a year ago.
NXS.CA Yearly Shares OutstandingNXS.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M
NXS.CA Yearly Total Debt VS Total AssetsNXS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

2.2 Solvency

  • NXS has an Altman-Z score of -30.71. This is a bad value and indicates that NXS is not financially healthy and even has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -30.71
ROIC/WACCN/A
WACCN/A
NXS.CA Yearly LT Debt VS Equity VS FCFNXS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M 6M

2.3 Liquidity

  • NXS has a Current Ratio of 0.04. This is a bad value and indicates that NXS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NXS has a Quick Ratio of 0.04. This is a bad value and indicates that NXS is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
NXS.CA Yearly Current Assets VS Current LiabilitesNXS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. NXS.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 765.31% over the past year.
EPS 1Y (TTM)765.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2541.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

2

4. NXS.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 4.43, the valuation of NXS can be described as very cheap.
  • The average S&P500 Price/Earnings ratio is at 25.71. NXS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.43
Fwd PE N/A
NXS.CA Price Earnings VS Forward Price EarningsNXS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXS.CA Per share dataNXS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NXS.CA Dividend Analysis

5.1 Amount

  • No dividends for NXS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NXS.CA Fundamentals: All Metrics, Ratios and Statistics

NEXUS GOLD CORP- A

TSX-V:NXS (3/12/2026, 7:00:00 PM)

0.31

-0.02 (-6.06%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)12-30
Earnings (Next)06-01
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners64.44%
Ins Owner ChangeN/A
Market Cap4.50M
Revenue(TTM)N/A
Net Income(TTM)126.40K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.43
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.07
EY22.58%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 9.41%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-71.2%
ROA(5y)-67.65%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z -30.71
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)369.66%
Cap/Depr(5y)2387.85%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)765.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2541.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-41.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y38.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.72%
OCF growth 3YN/A
OCF growth 5YN/A

NEXUS GOLD CORP- A / NXS.CA Fundamental Analysis FAQ

What is the fundamental rating for NXS stock?

ChartMill assigns a fundamental rating of 1 / 10 to NXS.CA.


Can you provide the valuation status for NEXUS GOLD CORP- A?

ChartMill assigns a valuation rating of 2 / 10 to NEXUS GOLD CORP- A (NXS.CA). This can be considered as Overvalued.


What is the profitability of NXS stock?

NEXUS GOLD CORP- A (NXS.CA) has a profitability rating of 0 / 10.


What is the valuation of NEXUS GOLD CORP- A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for NEXUS GOLD CORP- A (NXS.CA) is 4.43 and the Price/Book (PB) ratio is -29.13.